Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | Best Practices Reports | Delivering Maximum Brand Impact Via Pharmaceutical Market Analytics

Delivering Maximum Brand Impact Via Pharmaceutical Market Analytics

Market analytics functions play a key role in helping pharmaceutical and biotechnology companies make informed decisions, avoid risk, and uncover opportunities for growth. Although market analytics insights can be vital to corporate success, the function’s full value often remains unrealized.

Best Practices, LLC undertook this research to help executives who oversee or interact with market analytics groups understand how to maximize the business value of analytics through optimal structuring, staffing, and positioning of analytics activities. Executives can use this information to demonstrate business value and win the recognition and resources needed to achieve and sustain high performance levels.

This research focused on major topic areas: (1) hiring for market analytics performance excellence, (2) delivering high-impact services, (3) building effective relationships with key stakeholders, (4) structuring to support healthy product growth, and (5) winning corporate recognition and support. Specific areas of coverage include:

- Analytics activities with the maximum impact on the business

- Tactics for increasing the value of analytics organizations

- Drivers of growth for analytics groups

- Models of analytics organization evolution

- Extent of outsourcing of analytics functions

- Essential skills, experiences, and attributes for employee success in analytics roles

- Relationships with internal stakeholders and collaborators

- Program performance measurement

- Executives’ lessons learned for building a high-performing analytics function

Abbott Laboratories; Xanodyne Pharmaceuticals; Vertex Pharmaceuticals; Shire; Sepracor; Sanofi-Aventis; Purdue Pharma; Ortho Biotech; Novartis; Medrad; Mead Johnson; Genzyme; Eli Lilly; Eisai; DSM Pharmaceutical; Cubist Pharmaceuticals; Boehringer Ingelheim; Aton Pharma; Amylin; Amgen; Alcon; pharmaceutical; health care; consumer products; biotech; market analytics; biotechnology; structuring; staffing; positioning; high performance; market analytics performance excellence; high-impact services; effective relationships; stakeholders; product growth; corporate recognition; market research; brand analytics; business development; market intelligence; individual analytics activities; growth drivers; activities; staffing; organization; structure; thought leaders
Table of Contents

Price

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions